Hong Kong attracts wave of biotech IPO filings amid AI drug research boom

More than 10 loss-making biotechnology companies have filed for Hong Kong stock exchange listings this year, bringing cutting-edge drugs and artificial intelligence-powered drug discovery platforms to market, as the city’s bourse presses ahead with reforms aimed at supporting the real economy. The latest applications came as healthcare and biotechnology equity capital market activity – stock sales by companies and their shareholders – in Hong Kong reached US$15.6 billion last year, the second...


57 h.
Technology
ID: 3095958075726631579


Similar News expand_more


Economics
Technology
Technology
Technology
Technology
Economics
Technology
Technology
Science
Technology
Technology
Technology
Technology
Economics
Science
Technology
Science
Economics
Crime
Real Estate
Economics
Technology
Technology
Education
Economics
Economics
Technology
Technology
Technology
Weather
Technology
Technology
Economics
Technology
Technology
Economics
Technology
Economics
Technology
Technology
Economics
Science
Technology
Technology
Technology
Technology
Economics
Politics
Technology
Popular countries based on strong economic and political relations

Add Watch Country

arrow_drop_down